These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26712048)

  • 1. Neutrophil to lymphocyte ratio as a reliable marker to predict insulin resistance and fibrosis stage in chronic hepatitis C virus infection.
    Abdel-Razik A; Mousa N; Besheer TA; Eissa M; Elhelaly R; Arafa M; El-Wakeel N; Eldars W
    Acta Gastroenterol Belg; 2015 Dec; 78(4):386-92. PubMed ID: 26712048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum α-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story.
    Abdel-Razik A; Mousa N; Abdel-Aziz M; Elhelaly R; Elzehery R; Zalata K; Elkashef W; Fouda O; Awad M; Hafez M; Eldars W
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):313-22. PubMed ID: 26618566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.
    Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease.
    Alsebaey A; Elhelbawy M; Waked I
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):207-211. PubMed ID: 29240565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of the Neutrophil-to-lymphocyte Ratio and Platelet Morphologic Parameters in Predicting Hepatic Fibrosis in Chronic Hepatitis C Patients.
    Coskun BD; Dizdar OS; Baspınar O; Ortaköylüoğlu A
    Ann Clin Lab Sci; 2016 Jul; 46(4):380-6. PubMed ID: 27466297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The platelet-to-lymphocyte ratio, superior to the neutrophil-to-lymphocyte ratio, correlates with hepatitis C virus infection.
    Meng X; Wei G; Chang Q; Peng R; Shi G; Zheng P; He F; Wang W; Ming L
    Int J Infect Dis; 2016 Apr; 45():72-7. PubMed ID: 26948479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
    Helaly GF; Hussein NG; Refai W; Ibrahim M
    Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].
    Hui JM; Sud A; Farrell GC; Bandara P; Byth K; Kench JG; McCaughan GW; George J
    Gastroenterology; 2003 Dec; 125(6):1695-704. PubMed ID: 14724822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of inflammatory and anti-inflammatory cytokines with insulin resistance in chronic hepatitis C.
    Hung CH; Lee CM; Chen CH; Hu TH; Jiang SR; Wang JH; Lu SN; Wang PW
    Liver Int; 2009 Aug; 29(7):1086-93. PubMed ID: 19302182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study.
    Lecube A; Hernández C; Genescà J; Simó R
    Diabetes Care; 2006 May; 29(5):1096-101. PubMed ID: 16644643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.
    Cua IH; Hui JM; Bandara P; Kench JG; Farrell GC; McCaughan GW; George J
    Hepatology; 2007 Jul; 46(1):66-73. PubMed ID: 17596870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis].
    Kalyuzhin OV; Ponezheva ZB; Semenova IV; Khokhlova ON; Serebrovskaya LV; Guseva TS; Parshina OV; Maleev VV
    Ter Arkh; 2017; 89(11):14-20. PubMed ID: 29260741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HOMA-IR in patients with chronic hepatitis C].
    Botshorishvili T; Vashakidze E
    Georgian Med News; 2012 Feb; (203):33-7. PubMed ID: 22466538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis C infection is associated with insulin resistance and lipid profiles.
    Dai CY; Yeh ML; Huang CF; Hou CH; Hsieh MY; Huang JF; Lin IL; Lin ZY; Chen SC; Wang LY; Chuang WL; Yu ML; Tung HD
    J Gastroenterol Hepatol; 2015 May; 30(5):879-84. PubMed ID: 23808794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
    Adinolfi LE; Nevola R; Guerrera B; D'Alterio G; Marrone A; Giordano M; Rinaldi L
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1379-1382. PubMed ID: 29228501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C.
    Mera K; Uto H; Mawatari S; Ido A; Yoshimine Y; Nosaki T; Oda K; Tabu K; Kumagai K; Tamai T; Moriuchi A; Oketani M; Shimada Y; Hidaka M; Eguchi S; Tsubouchi H
    BMC Gastroenterol; 2014 Feb; 14():27. PubMed ID: 24524410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.